Nestlé has voluntarily initiated a global recall of its SMA baby formula and follow-up formula after detecting potential contamination with cereulide bacteria, a heat-resistant toxin linked to persistent vomiting, diarrhea and lethargy in infants. The recall covers products sold in more than 25 European countries—including the UK, Italy and France—as well as nearly a dozen markets across South America, Asia and Africa. Batch numbers for affected lots are listed on country-specific Nestlé websites, and the company is urging parents to verify their product codes and consult pediatricians if they have health concerns.

According to Nestlé’s statement, the contamination risk originated from a quality issue in an ingredient supplied by its primary oil vendor. The presence of cereulide in oils is described as highly unusual; the supplier is conducting a full root-cause analysis in coordination with Nestlé’s quality teams. The company emphasized that no illnesses have been reported to date, characterizing the recall as an abundance-of-caution measure to safeguard infant health and maintain trust in its nutrition portfolio.

In the latest update, Nestlé expanded the recall to include batches distributed in China and Brazil, following official health ministry alerts in those countries. This marks a significant widening from the initial European focus and adds complexity to the logistics of product containment and replacement. Nestlé is coordinating with local regulators to manage returns, distribute safe stock and communicate directly with healthcare providers and retailers in each region.

In response to the recall announcement, Nestlé’s ADRs (NSRGF) experienced a roughly 2% decline in European trading sessions, reflecting investor concerns over potential costs related to product retrieval, replacement and reputational damage. Analysts estimate that direct recall expenses, including supply-chain adjustments and marketing support for substituted products, could translate into mid-single-digit million-dollar charges in the current quarter. Longer-term effects will depend on the timing of resumed full production and consumer confidence recovery.